MATINAS BIOPHARMA

matinas-biopharma-logo

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections. The company develops orally delivered therapeutics based on a proprietary, lipid crystal drug delivery platform called cochleate delivery technology. Its lead product candidate is MAT 2203, an oral formulation of the broad spectrum anti-fungal drug amphotericin B that is in Phase II study for the treatment of fungal... infections. The company is also involved in developing MAT2501, an orally-administered, encochleated formulation of amikacin for acute bacterial infections, including non-tuberculous mycobacterium (NTM) and multi-drug resistant gram negative bacterial infections. In addition, it is exploring development and partnership options for MAT9001, a prescription-only omega-3 fatty acid-based composition under development for hypertriglyceridemia; and MAT8800 discovery program, which intends to identify product candidates derived from omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.

#SimilarOrganizations #People #Financial #Event #Website #More

MATINAS BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2011-01-01

Address:
Tarpon Springs, Florida, United States

Country:
United States

Website Url:
http://www.matinasbiopharma.com

Total Employee:
11+

Status:
Active

Contact:
1(908) 443-1860

Email Addresses:
[email protected]

Total Funding:
58.74 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network


Similar Organizations

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

kathryn-penkus-corzo_image

Kathryn Penkus Corzo Board of Directors @ MATINAS BIOPHARMA
Board_member
2021-01-01

natasha-giordano_image

Natasha Giordano Board Director @ MATINAS BIOPHARMA
Board_member
2020-09-01

Current Employees Featured

theresa-matkovits_image

Theresa Matkovits
Theresa Matkovits Chief Development Officer @ MATINAS BIOPHARMA
Chief Development Officer
2018-10-01

thomas-hoover_image

Thomas Hoover
Thomas Hoover Chief Business Officer @ MATINAS BIOPHARMA
Chief Business Officer
2021-12-01

not_available_image

Terry Ferguson
Terry Ferguson Chief Medical Officer @ MATINAS BIOPHARMA
Chief Medical Officer
2019-02-01

jerome-d-jabbour_image

Jerome D. Jabbour
Jerome D. Jabbour Chief Executive Officer @ MATINAS BIOPHARMA
Chief Executive Officer
2012-01-01

keith-kucinski_image

Keith Kucinski
Keith Kucinski Chief Financial Officer @ MATINAS BIOPHARMA
Chief Financial Officer
2019-01-01

james-j-ferguson_image

James J. Ferguson
James J. Ferguson Chief Medical Officer @ MATINAS BIOPHARMA
Chief Medical Officer
2019-02-01

raphael-j-mannino_image

Raphael J. Mannino
Raphael J. Mannino Chief Scientific Officer @ MATINAS BIOPHARMA
Chief Scientific Officer
2015-01-01

abdel-a-fawzy_image

Abdel A. Fawzy
Abdel A. Fawzy Co-Founder and Executive VP @ MATINAS BIOPHARMA
Co-Founder and Executive VP
2011-01-01

hui-liu_image

Hui Liu
Hui Liu Chief Technology Officer @ MATINAS BIOPHARMA
Chief Technology Officer
2020-12-01

Founder


abdel-a-fawzy_image

Abdel A. Fawzy

jerome-d-jabbour_image

Jerome D. Jabbour

roelof-rongen_image

Roelof Rongen

Stock Details


Company's stock symbol is NYSEMKT:MTNB

Acquisitions List

Date Company Article Price
2015-01-30 Aquarius Biotechnologies Aquarius Biotechnologies acquired by MATINAS BIOPHARMA N/A

Investors List

sternaegis-ventures_image

SternAegis

SternAegis investment in Venture Round - MATINAS BIOPHARMA

Official Site Inspections

http://www.matinasbiopharma.com

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "MATINAS BIOPHARMA" on Search Engine